High blood pressure is one of the most common health problems in the world. More than 1.3 billion people are affected by the condition, which is often called a “silent killer” because it may not cause noticeable symptoms for many years.
If left untreated, high blood pressure can damage blood vessels and increase the risk of serious health problems such as heart attacks, strokes, kidney failure, and vision loss.
To lower blood pressure and reduce these risks, doctors often prescribe medications known as RAS inhibitors. These drugs have been used for many years and are among the most common treatments for hypertension. They help relax blood vessels, making it easier for blood to flow through the body and reducing the strain on the heart.
RAS inhibitors work by blocking a natural hormone system in the body called the renin-angiotensin system, or RAS. This system plays a key role in controlling blood pressure.
When blood pressure falls, special cells in the kidneys release an enzyme called renin. This starts a chain of events that helps raise blood pressure back to normal. By blocking this process, RAS inhibitors help keep blood pressure under control.
These medications are generally considered safe and effective when used under medical supervision. However, doctors have long known that some patients can develop kidney-related side effects while taking them. Until recently, scientists did not fully understand why these problems occurred.
Now, researchers at the University of Virginia School of Medicine have uncovered new clues. Their study suggests that long-term use of certain RAS inhibitors may cause important changes inside the kidneys that could reduce the organs’ ability to filter waste from the blood.
The research was published in the journal Circulation Research.
To investigate what happens inside the kidneys, the scientists used advanced imaging techniques that allowed them to examine kidney structures in remarkable detail. They focused on the cells that normally produce renin. Under healthy conditions, these cells help regulate blood pressure and support normal kidney function.
The researchers discovered that after long-term exposure to RAS inhibitors, these renin-producing cells became unusually active. Instead of remaining in their normal state, they appeared to change back into a more primitive form similar to cells seen during early development before birth.
As these altered cells grew larger and more active, they began producing excessive amounts of renin and other substances. This triggered a series of physical changes within the kidneys.
The scientists observed the growth of extra nerve fibers around small blood vessels in the kidneys. They also found a buildup of immature muscle-like cells and increasing amounts of scar tissue surrounding tiny arteries known as arterioles. In addition, immune and inflammatory cells moved into the affected areas.
According to the researchers, these changes may interfere with the kidney’s normal structure and function. Although the kidneys continue trying to regulate blood pressure by producing more renin, their ability to perform their most important task—filtering waste products from the blood—may gradually become impaired.
Dr. Manako Yamaguchi, one of the study’s researchers, explained that three-dimensional imaging revealed clear evidence of nerve overgrowth, thickening of small arteries, and accumulation of immune cells after prolonged treatment with RAS inhibitors.
These findings helped the team better understand how the medications may affect kidney tissue over time.
Another researcher, Dr. Maria Luisa S. Sequeira-Lopez, said the team now wants to learn more about how kidney cells, nerve cells, and immune cells communicate with one another during long-term treatment. Understanding these interactions could help scientists develop safer approaches to controlling blood pressure.
The findings do not mean that patients should stop taking their prescribed blood pressure medications. High blood pressure remains a serious and potentially life-threatening condition, and these medications continue to provide important benefits for many people.
Patients should always consult their healthcare providers before making any changes to their treatment plans.
However, the study does raise important questions about the long-term effects of some blood pressure drugs on kidney health. It also highlights the need for continued monitoring of kidney function in patients who take these medications for many years.
The researchers believe their discovery could eventually lead to improved treatments that control blood pressure while reducing the risk of kidney damage. Future medications may be designed to target blood pressure more precisely without triggering the cellular changes observed in this study.
As scientists continue to explore the relationship between blood pressure treatment and kidney health, this research offers valuable new insight into how the body responds to long-term medication use.
The findings may help doctors develop better strategies to protect both the heart and the kidneys, improving health outcomes for millions of people worldwide.
If you care about blood pressure, please read studies about blood pressure drug that may increase risk of sudden cardiac arrest, and these teas could help reduce high blood pressure.
For more health information, please see recent studies about nutrient that could strongly lower high blood pressure, and results showing this novel antioxidant may help reverse blood vessels aging by 20 years.
Copyright © 2026 Knowridge Science Report. All rights reserved.
